Funding drives viral challenge agent development forward
CDMO Naobios, a provider of bioprocess development and GMP production of clinical batches of virus-based products, has plans to manufacture a human viral challenge agent for evaluating the effectiveness of vaccines in preventing infections. Click to read more...
United Kingdom Saint Herblain Pays De La Loire Eric Le Forestier Melinda Gates Foundation Controlled Human Infection Model
Source: labmate-online.com